Cargando…

Tissue factor upregulation is associated with SARS‐CoV‐2 in the lungs of COVID‐19 patients

BACKGROUND: A substantial proportion of patients infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) develop severe/critical coronavirus disease 2019 (COVID‐19) characterized by acute respiratory distress syndrome (ARDS) with thrombosis. OBJECTIVES: We tested the hypothesis th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Subrahmanian, Sandeep, Borczuk, Alain, Salvatore, Steven, Fung, Kar‐Ming, Merrill, Joan T., Laurence, Jeffrey, Ahamed, Jasimuddin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565501/ https://www.ncbi.nlm.nih.gov/pubmed/34236752 http://dx.doi.org/10.1111/jth.15451

Ejemplares similares

Higher Tissue Factor (TF) Expression in the Lungs of COVID-19 Pneumonia Patients Than Patients with Acute Respiratory Distress Syndrome: Association with Thrombi Formation
por: Subrahmanian, Sandeep, et al.
Publicado: (2020)

Defibrotide mitigates endothelial cell injury induced by plasmas from patients with COVID-19 and related vasculopathies
por: Elhadad, Sonia, et al.
Publicado: (2023)

Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches
por: Ahamed, Jasimuddin, et al.
Publicado: (2022)

Megakaryocyte/platelet-derived TGF-β1 inhibits megakaryopoiesis in bone marrow by regulating thrombopoietin production in liver
por: Gostynska, Sandra, et al.
Publicado: (2022)

The spatio-temporal landscape of lung pathology in SARS-CoV-2 infection
por: Rendeiro, André Figueiredo, et al.
Publicado: (2020)

SARS-CoV-2 vaccines in patients with SLE
por: Tang, Wei, et al.
Publicado: (2021)

HIV-associated cardiovascular disease: importance of platelet activation and cardiac fibrosis in the setting of specific antiretroviral therapies
por: Laurence, Jeffrey, et al.
Publicado: (2018)

Intervention in COVID-19 linked hypercoaguable states characterized by circuit thrombosis utilizing a direct thrombin inhibitor
por: Seshadri, Madhav, et al.
Publicado: (2020)

SARS-CoV-2 in penile tissue
por: Thomas, Tim
Publicado: (2022)

L-SIGN is a receptor on liver sinusoidal endothelial cells for SARS-CoV-2 virus
por: Kondo, Yuji, et al.
Publicado: (2021)

Severe aortic stenosis patient risk during the COVID-19 pandemic
por: Ahamed, Jasimuddin
Publicado: (2020)

SARS-CoV-2 antibody seroconversion in care home
por: Shang, Joan, et al.
Publicado: (2020)

Spatial resolution of SARS-CoV-2 lung infection
por: Pia, Luisanna
Publicado: (2020)

Therapeutic Interception of Early Lung Adenocarcinoma Progression: Not Just How, but When?
por: Borczuk, Alain C.
Publicado: (2021)

Prognostic considerations of the new World Health Organization classification of lung adenocarcinoma
por: Borczuk, Alain C.
Publicado: (2016)

Lymphocytes upregulate CD36 in adipose tissue and liver
por: Couturier, Jacob, et al.
Publicado: (2019)

SARS-CoV-2 Infection Prompts IL-1β-Mediated Inflammation and Reduces IFN-λ Expression in Human Lung Tissue
por: Vezzani, Bianca, et al.
Publicado: (2022)

Cross-reactive tissue-resident CD8(+) T cells may provide first line of defence against SARS-CoV-2
por: Flemming, Alexandra
Publicado: (2021)

SARS-CoV-2 on the neural battleground
por: Pavillet, Clara Eléonore, et al.
Publicado: (2020)

SARS-CoV-2 likes it cool
por: Soares-Schanoski, Alessandra
Publicado: (2020)

Inactivated vaccine for SARS-CoV-2
por: Risson, Emma
Publicado: (2020)

Clotting and SARS-CoV-2 entry
por: Hofer, Ursula
Publicado: (2022)

Histone mimicry by SARS-CoV-2
por: York, Ashley
Publicado: (2022)

The loss of cardiac SIRT3 decreases metabolic flexibility and proteostasis in an age-dependent manner
por: Li, Ping, et al.
Publicado: (2022)

Tropism of SARS-CoV-2, SARS-CoV, and Influenza Virus in Canine Tissue Explants
por: Bui, Christine H T, et al.
Publicado: (2021)

Comparative Performance Evaluation of Personal Protective Measures and Antiviral Agents Against SARS-CoV-2 Variants: A Narrative Review
por: Haque, Md Anamul, et al.
Publicado: (2023)

Immune correlates of SARS-CoV-2 protection
por: Brown, Matthew
Publicado: (2020)

SARS-CoV-2: too infectious to handle?
por: Coveney, Clarissa, et al.
Publicado: (2020)

Getting to the (germinal) centre of SARS-CoV-2
por: Richter, Felix Clemens, et al.
Publicado: (2020)

SARS-CoV-2 detection goes mobile
por: Clyde, Dorothy
Publicado: (2020)

Mapping host restriction of SARS-CoV-2
por: Gea-Mallorquí, Ester
Publicado: (2020)

Searching for relatives of SARS-CoV-2 in bats
por: York, Ashley
Publicado: (2021)

SARS-CoV-2 ‘super-permissive’ cells
por: Hofer, Ursula
Publicado: (2022)

SARS-CoV-2 tunnels to new cells
por: Hofer, Ursula
Publicado: (2022)

HCQ use not protective against SARS-CoV-2
por: Onuora, Sarah
Publicado: (2020)

SARS-CoV-2 has a sweet tooth
por: Cavounidis, Athena, et al.
Publicado: (2020)

SARS-CoV-2-specific T cells without antibodies
por: Bozkus, Cansu Cimen
Publicado: (2020)

CRISPRing for host genes regulating SARS-CoV-2
por: Lu, Fangfang, et al.
Publicado: (2020)

SARS-CoV-2 in patients with chronic liver disease
por: Hindson, Jordan
Publicado: (2020)

Antibody responses to SARS-CoV-2 short-lived
por: Vabret, Nicolas
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9qracoknpfa187cjqdeabmjje9